Claim Missing Document
Check
Articles

Found 2 Documents
Search

HUBUNGAN KOMPOSISI TUBUH DAN TINGKAT AKTIVITAS FISIK DENGAN KEJADIAN NYERI MUSKULOSKELETAL PADA PEKERJA MINIMARKET Hasbi, Alfian; Laeto, Arwan Bin; William, Jessica Audrey; Zulissetiana, Eka Febri; Santoso, Budi
ASSYIFA : Jurnal Ilmu Kesehatan Vol. 3 No. 1 (2025)
Publisher : Forind Press

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.62085/ajk.v3i1.129

Abstract

Musculoskeletal pain is acute or chronic pain, either persistent or recurring, that affects bones, muscles, ligaments, tendons, and nerves. According to Riset Kesehatan Dasar tahun 2018, the prevalence of musculoskeletal diseases in Indonesia has reached 7,3%. One of the risk factors is body composition and physical activity. This study aims to determine the relationship between body composition and physical activity with musculoskeletal pain among minimarket workers in Palembang City. An observational analytic study with a cross-sectional design was conducted on 50 respondents. Body composition was measured using Bioelectrical Impedance Analysis, while data on physical activity levels and musculoskeletal pain were collected using the International Physical Activity Questionnaire-Short Form and the Nordic Body Map Questionnaire. The study results show that the majority of minimarket workers had overfat body composition (32%); moderate physical activity levels (46%); and low risk of musculoskeletal pain (38%), with the most common areas of pain were the back and waist (40%). Bivariate analysis using Pearson’s Chi-Square test between body composition and musculoskeletal pain showed PR = 15.625 and p-value < 0.001. Meanwhile, the analysis of physical activity levels and musculoskeletal pain showed PR = 2.311 and p-value = 0.166. Thus, there is a significant relationship between body composition and musculoskeletal pain. However, there is an insignificant relationship between physical activity levels and musculoskeletal pain among minimarket workers in Palembang City.
MOMORDICA CHARANTIA L. (PARE) SEBAGAI AGEN HIPOGLIKEMIK DALAM MANAJEMEN DIABETES MELITUS TIPE 2 William, Jessica Audrey; Ananta, Vito; Adiputra, Ricky Fajar; Adenina, Syarinta
Bahasa Indonesia Vol 6 No 1 (2025): Prominentia Medical Journal
Publisher : Universitas Ciputra Surabaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37715/pmj.v6i1.5489

Abstract

Background: Diabetes Mellitus is a condition characterized by consistently high blood glucose levels due to a chronic metabolic disorder. Type 2 diabetes mellitus accounts for 90% of all cases. According to the 10th edition of the International Diabetes Federation report, Indonesia ranks fifth in the world for the number of type 2 diabetes patients, with 19.5 million affected individuals. Efforts to address the rise in type 2 diabetes cases require effective management to maintain normal blood glucose levels. Currently, oral hypoglycemic drugs are the preferred treatment for type 2 diabetes. However, potential side effects can raise concerns among patients. As a result, alternative approaches, such as herbal therapy, may help reduce the prevalence of type 2 diabetes. Momordica charantia L. is known for its hypoglycemic properties. Methods: The literature search is conducted in PubMed, ScienceDirect, and ClinicalKey databases. The articles used were those published in the last 10 years, and the keywords included "type 2 diabetes," "Momordica charantia L.," "bitter melon," and "blood glucose." Results: Momordica charantia L. contains many compounds with antidiabetic properties. These compounds include polysaccharides, peptides, terpenoids, saponins, alkaloids, flavonoids, and others. Momordica charantia L. contains the insulin-mimetic compound mclRBP-19, which is associated with a decrease in FBG and HbA1c levels. Triterpenoids have been found to stimulate GLUT-4 translocation in muscle and fat cells, as well as inhibit PTP1B activity. Additionally, charantin is known to inhibit DPP4 activity. Conclusion: Momordica charantia L. has the potential to lower blood glucose levels in type 2 diabetes patients through its bioactive components.